Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Nuclear receptors in bone physiology and diseases.

Imai Y, Youn MY, Inoue K, Takada I, Kouzmenko A, Kato S.

Physiol Rev. 2013 Apr;93(2):481-523. doi: 10.1152/physrev.00008.2012. Review.

2.

Regulation of bone metabolism by nuclear receptors.

Imai Y, Kondoh S, Kouzmenko A, Kato S.

Mol Cell Endocrinol. 2009 Oct 30;310(1-2):3-10. doi: 10.1016/j.mce.2008.08.015. Epub 2008 Aug 22. Review.

PMID:
18789372
3.

Evolution of the repertoire of nuclear receptor binding sites in genomes.

Cotnoir-White D, Laperrière D, Mader S.

Mol Cell Endocrinol. 2011 Mar 1;334(1-2):76-82. doi: 10.1016/j.mce.2010.10.021. Epub 2010 Nov 4. Review.

PMID:
21056084
4.

Nuclear receptor mediated gene regulation through chromatin remodeling and histone modifications.

Kishimoto M, Fujiki R, Takezawa S, Sasaki Y, Nakamura T, Yamaoka K, Kitagawa H, Kato S.

Endocr J. 2006 Apr;53(2):157-72. Review.

5.

Krüppel-like factors are effectors of nuclear receptor signaling.

Knoedler JR, Denver RJ.

Gen Comp Endocrinol. 2014 Jul 1;203:49-59. doi: 10.1016/j.ygcen.2014.03.003. Epub 2014 Mar 15. Review.

6.

Endogenous ligands for nuclear receptors: digging deeper.

Schupp M, Lazar MA.

J Biol Chem. 2010 Dec 24;285(52):40409-15. doi: 10.1074/jbc.R110.182451. Epub 2010 Oct 18. Review.

7.

The role of estrogen receptor α in the regulation of bone and growth plate cartilage.

Börjesson AE, Lagerquist MK, Windahl SH, Ohlsson C.

Cell Mol Life Sci. 2013 Nov;70(21):4023-37. doi: 10.1007/s00018-013-1317-1. Epub 2013 Mar 21. Review.

PMID:
23516016
8.

Nuclear receptor drug discovery.

Chen T.

Curr Opin Chem Biol. 2008 Aug;12(4):418-26. doi: 10.1016/j.cbpa.2008.07.001. Epub 2008 Jul 26. Review.

PMID:
18662801
9.

The dynamics of nuclear receptors and nuclear receptor coregulators in the pathogenesis of endometriosis.

Han SJ, O'Malley BW.

Hum Reprod Update. 2014 Jul-Aug;20(4):467-84. doi: 10.1093/humupd/dmu002. Epub 2014 Mar 14. Review.

10.

Therapeutic potential of selective modulators of nuclear receptor action.

Resche-Rigon M, Gronemeyer H.

Curr Opin Chem Biol. 1998 Aug;2(4):501-7. Review.

PMID:
9736923
11.

Structure-activity relationship of nuclear receptor-ligand interactions.

Greschik H, Moras D.

Curr Top Med Chem. 2003;3(14):1573-99. Review.

PMID:
14683516
12.

Nuclear hormone receptor signaling in amphioxus.

Schubert M, Brunet F, Paris M, Bertrand S, Benoit G, Laudet V.

Dev Genes Evol. 2008 Dec;218(11-12):651-65. doi: 10.1007/s00427-008-0251-y. Epub 2008 Sep 25.

PMID:
18815806
13.

Beyond the ligand-binding pocket: targeting alternate sites in nuclear receptors.

Caboni L, Lloyd DG.

Med Res Rev. 2013 Sep;33(5):1081-118. doi: 10.1002/med.21275. Epub 2012 Nov 26. Review.

PMID:
23344935
14.

General molecular biology and architecture of nuclear receptors.

Pawlak M, Lefebvre P, Staels B.

Curr Top Med Chem. 2012;12(6):486-504. Review.

15.

Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology.

Hofbauer LC, Heufelder AE.

J Mol Med (Berl). 2001 Jun;79(5-6):243-53. Review.

PMID:
11485016
16.

Pathogenesis of osteoporosis: concepts, conflicts, and prospects.

Raisz LG.

J Clin Invest. 2005 Dec;115(12):3318-25. Review.

17.

Noncanonical mechanisms to regulate nuclear receptor signaling.

Sadana P.

Future Med Chem. 2012 Jun;4(10):1307-33. doi: 10.4155/fmc.12.72. Review.

PMID:
22800372
18.

Sex steroids and bone.

Manolagas SC, Kousteni S, Jilka RL.

Recent Prog Horm Res. 2002;57:385-409. Review.

PMID:
12017554
19.

An integrated biological approach to nuclear receptor signaling in physiological control and disease.

Carlberg C, Dunlop TW.

Crit Rev Eukaryot Gene Expr. 2006;16(1):1-22. Review.

PMID:
16584379
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk